APA (7th ed.) Citation

M, W., C, S., CC, G., C, H., D, G., M, K., . . . P, M. (2025). Cancer-control outcomes with [177Lu]Lu-PSMA Radioligand Therapy in elderly, frail or comorbid mCRPC patients. Theranostics, 15(7), 2672. https://doi.org/10.7150/thno.108963

Chicago Style (17th ed.) Citation

M, Wenzel, et al. "Cancer-control Outcomes with [177Lu]Lu-PSMA Radioligand Therapy in Elderly, Frail or Comorbid MCRPC Patients." Theranostics 15, no. 7 (2025): 2672. https://doi.org/10.7150/thno.108963.

MLA (9th ed.) Citation

M, Wenzel, et al. "Cancer-control Outcomes with [177Lu]Lu-PSMA Radioligand Therapy in Elderly, Frail or Comorbid MCRPC Patients." Theranostics, vol. 15, no. 7, 2025, p. 2672, https://doi.org/10.7150/thno.108963.